Lonza Group Ltd
LONN: XSWX (CHE)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
CHF 287.00 | Twlpjz | Pkyhvqxx |
Narrow-Moat Lonza Reports Solid 1H 2022; Maintaining CHF 620 FVE, Shares Moderately Undervalued
Lonza reported solid half-year results driven by continued strong demand in its biologics and cell and gene segments. Revenue totaled nearly CHF 3 billion, representing a 17% increase from the prior year. Lonza’s results were in line with our expectations, and we maintain our fair value estimate of CHF 620 per share. The stock is currently trading in 3-star territory, about 6% below our fair value estimate. We maintain our narrow economic moat rating and stable moat trend.